Thank you for donating!

You can donate using the following services.

Mallinckrodt Responds to Global Community Questions on VTS-270 Trial

Posted: 30.11.18

Following Mallinckrodt’s announcement regarding early phase data from their VTS-270 study on 6th November, a comprehensive list of questions posed by the global NP-C community, was submitted to the company. You will find Mallinckrodt’s response to these questions below (you can also download the PDF here), accompanied by a video presentation from their Chief Scientific Officer, Steve Romano.

Please contact NPUK for further information, by email or telephone 0191 415 0693.